Sumitomo Pharma Co., Ltd. (TYO:4506)

Japan flag Japan · Delayed Price · Currency is JPY
2,297.00
+116.50 (5.34%)
At close: Jan 30, 2026
300.87%
Market Cap912.57B +313.9%
Revenue (ttm)453.40B +21.6%
Net Income110.09B
EPS277.11
Shares Out397.29M
PE Ratio8.29
Forward PE10.09
Dividendn/a
Ex-Dividend Daten/a
Volume6,080,300
Average Volume10,019,105
Open2,210.00
Previous Close2,180.50
Day's Range2,200.00 - 2,313.00
52-Week Range500.00 - 2,955.00
Beta0.45
RSI45.09
Earnings DateJan 30, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has coll... [Read more]

Sector Healthcare
Founded 1897
Employees 3,832
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4506
Full Company Profile

Financial Performance

Financial Statements